Erlotinib Completed Phase 2 Trials for Diffuse Intrinsic Pontine Glioma (DIPG) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01182350Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)